Barnes Akathisia Scale


Also found in: Wikipedia.

Barnes Akathisia Scale

A testing device—range of 0 to 14, with higher scores indicating greater severity—used to evaluate restlessness related to drug therapy.
Mentioned in ?
References in periodicals archive ?
13,16) Changes from baseline to endpoint in EPS, akathisia, and tardive dyskinesia were also evaluated in the LATUDA monotherapy and adjunctive therapy short-term and longer-term trials using the Simpson-Angus Scale (SAS), the Barnes Akathisia Scale (BAS), and the Abnormal Involuntary Movement Scale (AIMS), respectively.
13) EPS, akathisia, and dyskinesias were also examined using the Simpson-Angus Scale (SAS), the Barnes Akathisia Scale (BAS), and the Abnormal Involuntary Movement Scale (AIMS), respectively.
In the short-term, placebo-controlled schizophrenia and bipolar depression studies, data was objectively collected on the Simpson Angus Rating Scale (SAS) for extrapyramidal symptoms (EPS), the Barnes Akathisia Scale (BAS) for akathisia and the Abnormal Involuntary Movement Scale (AIMS) for dyskinesias.
Extrapyramidal symptoms were evaluated using the Simpson-Angus scale (Simpson and Angus 1979), Barnes Akathisia scale (Barnes 1989), and abnormal involuntary movement scale (AIMS) (National Institute of Mental Health 1976b).
A significant moderate effect of NAC was also seen on the Barnes Akathisia Scale, he reported.
They completed a daily food journal as well as the Functional Assessment of Cancer Therapy-General (FACT-G) Scale across four time periods, the Mini-Mental State Exam, the Simpson-Angus Scale, and the Barnes Akathisia Scale.
Additionally, iloperidone also had a similar akathisia profile to placebo, whereas ziprasidone was associated with a significant worsening of akathisia versus placebo on the Barnes Akathisia Scale (BAS), with 26 percent of patients experiencing a worsening of akathisia.
10) EPS, akathisia, and dyskinesia were also examined using the Simpson-Angus Scale (SAS), the Barnes Akathisia Scale (BAS), and the Abnormal Involuntary Movement Scale (AIMS), respectively.
EPS, akathisia, and tardive dyskinesia were examined using the SimpsonAngus Scale, the Barnes Akathisia Scale (BAS), and the Abnormal Involuntary Movement Scale (AIMS), respectively.
Extrapyramidal symptoms (EPS), akathisia, and tardive dyskinesia were examined using the Simpson-Angus Scale, the Barnes Akathisia Scale (BAS), and the Abnormal Involuntary Movement Scale (AIMS), respectively.
23) Changes from baseline to study endpoint in EPS, akathisia, and tardive dyskinesia were also evaluated using the Simpson Angus Rating Scale (SAS), the Barnes Akathisia Scale (BAS), and the Abnormal Involuntary Movement Scale (AIMS), respectively.
2) Regarding side effects, ziprasidone has demonstrated greater safety in terms of extrapyramidal symptoms and akathisia when objectively measured with the Extrapyramidal Symptom Rating Scale and Barnes Akathisia Scale.